SMC2 knockdown inhibits malignant progression of lung adenocarcinoma by upregulating BTG2 expression
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Structural maintenance of chromosomes 2 (SMC2) is upregulated in lung adenocarcinoma (LUAD), promoting cancer progression. Silencing SMC2 inhibits LUAD cell growth and metastasis by increasing BTG2 expression and inactivating key signaling pathways, suggesting SMC2 as a therapeutic target.
Area Of Science
- Oncology
- Molecular Biology
- Cancer Research
Background
- Lung adenocarcinoma (LUAD) is a leading cause of cancer mortality worldwide.
- Structural maintenance of chromosomes 2 (SMC2) is implicated in poor prognosis across multiple cancer types.
- The specific role of SMC2 in LUAD progression requires further elucidation.
Purpose Of The Study
- To investigate the role and underlying mechanisms of SMC2 in LUAD progression.
- To determine the prognostic significance of SMC2 expression in LUAD.
- To evaluate SMC2 as a potential therapeutic target for LUAD.
Main Methods
- Analysis of SMC2 expression in public LUAD databases and correlation with prognosis.
- In vitro studies involving SMC2 knockdown in LUAD cells to assess proliferation, migration, and invasion.
- Bulk RNA sequencing to identify molecular pathways affected by SMC2 modulation.
- In vivo experiments using mouse models (subcutaneous, intracranial, and metastasis) to evaluate the antineoplastic and anti-metastatic effects of SMC2 knockdown.
- Assessment of BTG2 (BTG anti-proliferation factor 2) expression and its role in mediating SMC2 effects.
Main Results
- SMC2 expression is elevated in LUAD tissues and cell lines, correlating with poorer patient prognosis.
- SMC2 knockdown significantly suppressed LUAD cell proliferation, migration, and invasion.
- SMC2 silencing led to the upregulation of BTG2 expression and inactivation of ERK and AKT signaling pathways.
- BTG2 knockdown reversed the anti-malignant effects of SMC2 downregulation.
- In vivo studies demonstrated that SMC2 knockdown effectively inhibited tumor formation and metastasis.
Conclusions
- SMC2 promotes LUAD progression and metastasis.
- SMC2 knockdown exerts anti-tumor effects by upregulating BTG2 and inhibiting ERK/AKT pathways.
- SMC2 represents a promising therapeutic target for the treatment of lung adenocarcinoma.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...